Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin launches Luforbec 100/6 μg pMDI
It is the first branded generic alternative to Fostair 100/6 μg pMDI for the treatment of asthma and COPD in the UK
FDA approves Cara’s drug for severe itching in kidney disease patients
The drug is designed to be administered three times a week after each dialysis
Israel’s COVID-19 vaccine boosters show signs of taming delta variant of coronavirus
Delta hit Israel in June, just as the country began to reap the benefits of one of the world’s fastest vaccine roll-outs
US FDA accepts Bristol Myers Squibb’s application for Orencia for priority review
If approved, Orencia would become the first therapy for the prevention of acute graft versus host disease (aGvHD)
Pfizer to acquire Trillium Therapeutics
Proposed acquisition strengthens Pfizer’s category leadership in oncology with addition of next-generation and investigational…
FDA approves first COVID-19 vaccine
Since 11th December, 2020, the Pfizer-BioNTech COVID-19 vaccine has been available under EUA in individuals 16 years of age and…
Vivera Pharmaceuticals receives US patent for Zicoh
Zicoh is a wireless, electronic and dose-controlled medication-delivery device manufactured by Vivera
Centre provides over 57 crore vaccine doses to states and UTs
Over 13 crore doses are in the pipeline
Zydus Cadila gets US FDA approval for Tofacitinib extended-release 22 mg tablet
Zydus was the first ANDA filer on Tofacitinib extended-release tablets 22 mg and
currently holds 180-day exclusivity on this…
Xeljanz receives marketing authorisation in EU to treat active polyarticular juvenile idiopathic…
This once-daily treatment is an alternative to the currently-approved Xeljanz 5 mg twice-daily treatment of PsA